FDA

Latest Stories

A demonstrator in favor of access to abortion pills places signage about the Supreme Court, Friday, April 21, 2023, outside the Supreme Court in Washington. (AP Photo/Jacquelyn Martin) **FILE**

Supreme Court leaves abortion pill access alone while case goes through courts

By Alex Swoyer - The Washington Times

Boxes of the drug mifepristone sit on a shelf at the West Alabama Women's Center in Tuscaloosa, Ala., on March 16, 2022. The Supreme Court is deciding whether women will face restrictions in getting a drug used in the most common method of abortion in the United States, while a lawsuit continues. (AP Photo/Allen G. Breed, File)

Supreme Court poised to rule on abortion pill restrictions

By Mark Sherman - Associated Press

A nurse administers a Moderna COVID-19 booster vaccine at an inoculation station next to Jackson State University in Jackson, Miss., Friday, Nov. 18, 2022. U.S. regulators on Tuesday, April 18, 2023, cleared another COVID-19 booster dose for older adults and people with weak immune systems so they can shore up protection this spring — while taking steps to make coronavirus vaccinations simpler for everyone else.(AP Photo/Rogelio V. Solis)

Extra spring COVID-19 booster cleared for certain Americans

By Lauran Neergaard - Associated Press

A patient prepares to take the first of two combination pills, mifepristone, for a medication abortion during a visit to a clinic in Kansas City, Kan., on Wednesday, Oct. 12, 2022. A federal appeals court has ruled that the abortion pill mifepristone can still be used for now but reduced the period of pregnancy when the drug can be taken and said it could not be dispensed by mail. (AP Photo/Charlie Riedel, File)

Justice Department takes abortion pill fight to Supreme Court

By Alex Swoyer - The Washington Times

New York Gov. Kathy Hochul speaks to reporters about legislation passed during a special legislative session in the Red Room at the state Capitol, July 1, 2022, in Albany, N.Y. For California, New York and some other states trying to position themselves as safe havens for those seeking abortions, a federal court ruling this week, Wednesday, April 12, 2023, could be a setback, adding barriers to obtaining one of the two drugs usually used in combination to end pregnancies with medication. (AP Photo/Hans Pennink, File)

Latest abortion pill ruling could hit some safe havens hard

By Geoff Mulvihill - Associated Press

The U.S. Supreme Court is seen at sunset, March 27, 2019, in Washington. Dance Laboratories is asking the Supreme Court to preserve access to its abortion pill free from restrictions imposed by lower court rulings, while a legal fight continues. (AP Photo/Alex Brandon)

Supreme Court greenlights FDA rules on use, distribution of abortion pill for now

By Alex Swoyer - The Washington Times

Court Ruling Against the FDA and Big Abortion Illustration by Greg Groesch/The Washington Times

Ending FDA’s ugly alliance with Big Abortion

By Erik Baptist

Boxes of the drug mifepristone sit on a shelf at the West Alabama Women's Center in Tuscaloosa, Ala., March 16, 2022. An “anti-vice” law from the 19th century is at the center of a new court ruling that could soon halt access to the leading abortion drug in the U.S. On Friday, April 7, 2023, a Trump-appointed judge in Texas sided with Christian conservatives in ruling that the Comstock, enacted in the 1870s, prohibits sending the long-used drug through the mail. (AP Photo/Allen G. Breed, File)

Abortion pill rulings in conflict: What happens next?

By Jessica Gresko and Mark Sherman - Associated Press

COVID-19 antigen home tests are photographed in New York on Wednesday, April 5, 2023. When the COVID-19 public health emergency ends in the U.S. in May 2023, you'll still have access to a multitude of tests but with one big difference: who pays for them. For the first time, you may have to pick up some or all of the costs, depending on your insurance coverage and whether the tests are done at home or in a doctor's office. (AP Photo/Patrick Sison)

Free COVID testing will fade with U.S. health emergency in May

By Matthew Perrone - Associated Press

Boxes of the drug mifepristone sit on a shelf at the West Alabama Women's Center in Tuscaloosa, Ala., March 16, 2022. Health and Human Services Secretary Xavier Becerra on Sunday, April 9, 2023, stressed that women for now continue to have access to the abortion medication mifepristone after the Texas judge stayed his ruling for a week so federal authorities could file a challenge. The drug was approved by the FDA in 2000. (AP Photo/Allen G. Breed, File)

Calls for feds to ignore court order blocking abortion drug are not based in reality, experts say

By Tom Howell Jr. - The Washington Times

Republican Nancy Mace talks to supporters during her election night party on Nov. 3, 2020, in Mount Pleasant, S.C. Mace is set to meet two GOP challengers on the debate stage, Monday, May 23, 2022, who are seeking to oust her from South Carolina's 1st Congressional District. (AP Photo/Mic Smith, File)

GOP Rep. Nancy Mace sides with Democrats urging Biden to ignore abortion pill ruling

By Valerie Richardson - The Washington Times

Bottles of the drug misoprostol sit on a table at the West Alabama Women's Center, March 15, 2022, in Tuscaloosa, Ala. Misoprostol induces uterus contractions that expel an embryo or fetus and other tissue. A federal judge in Texas will hear arguments Wednesday, March 15, 2023, in a high-stakes court case that could threaten access to abortion medication and blunt the authority of U.S. drug regulators. The lawsuit from Christian conservatives aimed at overturning the Food and Drug Administration’s approval of the abortion pill mifepristone. The drug, when used with a second pill, misoprostol, has become the most common method of abortion in the U.S. (AP Photo/Allen G. Breed, File)

Biden HHS secretary says ignoring court order against abortion pill is ‘on the table’

By Ramsey Touchberry - The Washington Times

Sen. Ron Wyden, D-Ore., speaks during a Senate Finance Committee hearing on Oct. 19, 2021, on Capitol Hill in Washington. (Mandel Ngan/Pool Photo via AP, File) ** FILE **

Wyden, AOC urge Biden to ‘ignore’ judge’s order blocking abortion pill

By Valerie Richardson - The Washington Times

Boxes of the drug mifepristone sit on a shelf at the West Alabama Women's Center in Tuscaloosa, Ala., March 16, 2022. A federal judge in Texas on Friday, April 7, 2023, ordered a hold on the U.S. approval of the abortion medication mifepristone, throwing into question access to the nation’s most common method of abortion in a ruling that waved aside decades of scientific approval. Federal lawyers representing the FDA are expected to swiftly appeal the ruling. (AP Photo/Allen G. Breed, File)

Judge blocks abortion pills nationwide while another judge exempts 17 blue states

By Valerie Richardson - The Washington Times

This image provided by Covis Pharma shows packaging for the company's Makena medication. The Food and Drug Administration on Thursday, April 6, 2023 ordered the immediate market withdrawal of a drug intended to prevent premature births, which has remained available for years despite data showing it doesn't help pregnant women. The decision follows repeated efforts by Swiss drugmaker Covis Pharma to keep Makena on the U.S. market while it conducted additional studies. (Covis Pharma via AP)

FDA forces unproven premature birth drug Makena off market

By Matthew Perrone - Associated Press

In this Saturday, Jan. 5, 2019, file photo, different kinds of baby formula line a shelf in Mankato, Minn. (Jackson Forderer/The Free Press via AP) ** FILE **

Baby formula is back on store shelves … mostly

By Susan Ferrechio - The Washington Times

Erik Baptist, right, and other legal team members with Alliance Defending Freedom exit the federal court building on Wednesday, March 15, 2023, in Amarillo, Texas, where a federal judge is expected to hear arguments in a lawsuit that takes aim at medication abortions. Pills are the the most common method for obtaining an abortion in the U.S. (AP Photo/David Erickson)

Texas judge hears arguments in challenge to FDA’s approval of abortion drug

By Valerie Richardson - The Washington Times

Boxes of the drug mifepristone sit on a shelf at the West Alabama Women's Center in Tuscaloosa, Ala., on March 16, 2022. A federal judge will hear arguments Wednesday, March 15, 2023, in a high-stakes court case that could threaten access to abortion medication and blunt the authority of U.S. drug regulators. (AP Photo/Allen G. Breed, File)

Abortion pill challenge goes before judge in Texas

By Sean Murphy and Matthew Perrone - Associated Press

A health worker administers a dose of COVID-19 vaccine during a vaccination clinic in Reading, Pa. on Sept. 14, 2021. On Friday, March 10, 2023, The Associated Press reported on stories circulating online incorrectly claiming the U.S. military has recorded a 500% increase in new HIV infections since COVID-19 vaccines were introduced. (AP Photo/Matt Rourke, File)

Congress’ pandemic probe asks whether Biden officials cut corners to fast-track vaccine approvals

By Joseph Clark - The Washington Times

Barbara Trout, who has an asthma disorder, holds a box of inhalation solution of Ipratropium Bromide and Albuterol Sulfate, prescribed medication at her home in Keizer, Ore., Wednesday, Oct. 14, 2020. (AP Photo/Andrew Selsky)

Shortage of liquid asthma medicine albuterol to worsen after manufacturer’s bankruptcy

By Brad Matthews - The Washington Times